| Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity A Zhernakova, A Kurilshikov, MJ Bonder, EF Tigchelaar, M Schirmer, ... Science 352 (6285), 565-569, 2016 | 725 | 2016 |
| Proton pump inhibitors affect the gut microbiome F Imhann, MJ Bonder, AV Vila, J Fu, Z Mujagic, L Vork, EF Tigchelaar, ... Gut 65 (5), 740-748, 2016 | 424 | 2016 |
| The effect of host genetics on the gut microbiome MJ Bonder, A Kurilshikov, EF Tigchelaar, Z Mujagic, F Imhann, AV Vila, ... Nature genetics 48 (11), 1407-1412, 2016 | 309 | 2016 |
| The gut microbiome contributes to a substantial proportion of the variation in blood lipids J Fu, MJ Bonder, MC Cenit, EF Tigchelaar, A Maatman, JAM Dekens, ... Circulation research 117 (9), 817-824, 2015 | 287 | 2015 |
| Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease F Imhann, AV Vila, MJ Bonder, J Fu, D Gevers, MC Visschedijk, ... Gut 67 (1), 108-119, 2018 | 241 | 2018 |
| Complex host genetics influence the microbiome in inflammatory bowel disease D Knights, MS Silverberg, RK Weersma, D Gevers, G Dijkstra, H Huang, ... Genome medicine 6 (12), 1-11, 2014 | 233 | 2014 |
| Gut microbiome structure and metabolic activity in inflammatory bowel disease EA Franzosa, A Sirota-Madi, J Avila-Pacheco, N Fornelos, HJ Haiser, ... Nature microbiology 4 (2), 293-305, 2019 | 127 | 2019 |
| The influence of proton pump inhibitors and other commonly used medication on the gut microbiota F Imhann, A Vich Vila, MJ Bonder, AG Lopez Manosalva, DPY Koonen, ... Gut Microbes 8 (4), 351-358, 2017 | 55 | 2017 |
| Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome AV Vila, F Imhann, V Collij, SA Jankipersadsing, T Gurry, Z Mujagic, ... Science translational medicine 10 (472), 2018 | 53 | 2018 |
| Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis R Alberts, EMG de Vries, EC Goode, X Jiang, F Sampaziotis, K Rombouts, ... Gut 67 (8), 1517-1524, 2018 | 23 | 2018 |
| Analysis of 1135 gut metagenomes identifies sex-specific resistome profiles T Sinha, A Vich Vila, S Garmaeva, SA Jankipersadsing, F Imhann, V Collij, ... Gut Microbes 10 (3), 358-366, 2019 | 16 | 2019 |
| Pooled Resequencing of 122 Ulcerative Colitis Genes in a Large Dutch Cohort Suggests Population-Specific Associations of Rare Variants in MUC2 MC Visschedijk, R Alberts, S Mucha, P Deelen, DJ De Jong, M Pierik, ... PLoS One 11 (8), e0159609, 2016 | 15 | 2016 |
| Genetic effects on the commensal microbiota in inflammatory bowel disease patients H Aschard, V Laville, ET Tchetgen, D Knights, F Imhann, P Seksik, ... PLoS genetics 15 (3), e1008018, 2019 | 14 | 2019 |
| Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease LM Spekhorst, F Imhann, EAM Festen, AA Van Bodegraven, NKH de Boer, ... BMJ open 7 (11), e016695, 2017 | 14 | 2017 |
| Presentation of a nationwide multicenter registry of intestinal failure and intestinal transplantation EG Neelis, AM Roskott, G Dijkstra, GJ Wanten, MJ Serlie, MM Tabbers, ... Clinical Nutrition 35 (1), 225-229, 2016 | 12 | 2016 |
| The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1 F Imhann, KJ Van der Velde, R Barbieri, R Alberts, MD Voskuil, AV Vila, ... BMC gastroenterology 19 (1), 5, 2019 | 10 | 2019 |
| HSPA6 is an ulcerative colitis susceptibility factor that is induced by cigarette smoke and protects intestinal epithelial cells by stabilizing anti-apoptotic Bcl-XL A Regeling, F Imhann, HH Volders, T Blokzijl, VW Bloks, RK Weersma, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1862 (4), 788-796, 2016 | 9 | 2016 |
| Impact of commonly used drugs on the composition and metabolic function of the gut microbiota AV Vila, V Collij, S Sanna, T Sinha, F Imhann, AR Bourgonje, Z Mujagic, ... Nature communications 11 (1), 1-11, 2020 | 7 | 2020 |
| Anti-inflammatory gut microbial pathways are decreased during Crohn’s disease exacerbations MAY Klaassen, F Imhann, V Collij, J Fu, C Wijmenga, A Zhernakova, ... Journal of Crohn's and Colitis 13 (11), 1439-1449, 2019 | 7 | 2019 |
| Genomic and expression analyses identify a disease-modifying variant for fibrostenotic Crohn’s disease MC Visschedijk, LM Spekhorst, SC Cheng, ES van Loo, BHD Jansen, ... Journal of Crohn's and Colitis 12 (5), 582-588, 2018 | 7 | 2018 |
Rinse WeersmaMD PhD Professor, Chair Dept of Gastroenterology and Hepatology, University Medical Center GroningenVerified email at umcg.nl
